Open | - |
Close | - |
Volume / Avg. | 0 / 287.651K |
Day Range | - - - |
52 Wk Range | 5.420 - 23.888 |
Market Cap | $95.431M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NYSE |
RSI | 45 |
Short Interest | 17.28% |
Days to Cover | 8 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Annovis Bio (NYSE: ANVS) through any online brokerage.
Other companies in Annovis Bio’s space includes: Vincerx Pharma (NASDAQ:VINC), Outlook Therapeutics (NASDAQ:OTLK), Anixa Biosciences (NASDAQ:ANIX), Vaxxinity (NASDAQ:VAXX) and CARISMA Therapeutics (NASDAQ:CARM).
The latest price target for Annovis Bio (NYSE: ANVS) was reported by Brookline Capital on Wednesday, February 28, 2024. The analyst firm set a price target for 9.00 expecting ANVS to fall to within 12 months (a possible -0.22% downside). 9 analyst firms have reported ratings in the last year.
The stock price for Annovis Bio (NYSE: ANVS) is $9.02 last updated March 18, 2024 at 4:37 PM EDT.
There are no upcoming dividends for Annovis Bio.
Annovis Bio’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Annovis Bio.
Annovis Bio is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.